listen early

to act effectively

An innovative solution to proactively manage heart failure

w

We develop AI-powered sentinels to revolutionize the management of chronic diseases as heart failure.

The Challenge of Heart Failure

26 million patients

suffer from HF in the world

10% of people

aged 70-85 suffer from severe HF

46 billion euros

are spent on emergency care in HF (US/EU)

w

We want to help physicians
to move patients away from emergency care.

w

Vision

To be a leading Health-as-a-Service Company giving a better life to all Heart Failure patients by turning in a heartbeat, emergency care into prevention

w

Mission

The mission of Sentinhealth is to design, develop & market medical products and services for Heart Failure patients’ follow-up to prevent decompensation.

This requires an affordable subcutaneous sensor that guarantees long-term real-world data acquisition and delivery.

The data collected is enriched and supplemented by Artificial Intelligence modules allowing Health Professionals to detect the very first signs of changes in the patient’s cardiac condition.

This early detection enables to adapt medical treatment on time, preventing the emergency hospitalization.

In doing so, we preserve the patient’s quality of life, we reduce the morbi-mortality, and, in addition, we tackle the economic burden of the healthcare system.

 

Our AI-powered Sentinel

Our AI-powered sentinel monitors daily heart activity and other early signs of evolving HF.

w

We strive to alert physicians
while home treatment adjustment is still an option.

a team of passionate optimists

w

We are a medtech startup founded in 2017
made of passionate healthtech innovators based in Paris & Grenoble.

Executive management team

Thibault PARMENTIER, Ph.D

Thibault PARMENTIER, Ph.D

CEO

Cindy MICHEL, Ph.D

Cindy MICHEL, Ph.D

CTO

Co-founders

Jean-Marc BOUREZ

Jean-Marc BOUREZ

Chairman & Cofounder

Pr. Philippe CINQUIN

Pr. Philippe CINQUIN

Cofounder

Dr. Marc LEMAIRE

Dr. Marc LEMAIRE

Cofounder

Strategic Committee

Jean-Marc BOUREZ

Jean-Marc BOUREZ

Chairman & Cofounder

Nicolas FÉLIX

Nicolas FÉLIX

Corporate Investor Principal advisor at Doliam

Sonia HEYMANN

Representative of unaffiliated investors

Eric GARNIER

Eric GARNIER

Investor at Angels Santé Entrepreneur

Mariana TSYMBROVSKA

Mariana TSYMBROVSKA

CEO at Grenoble Alpes University Tech Transfer Office - Floralis (non-voting member)

medical & scientific advisors

w

A core group of researchers and physicians has helped us
thinking out of the box.

Cardiology

  • Pr. Gilles BARONE-ROCHETTE (CHU, Grenoble Hospital)
  • Pr. François BOUCHER (TIMC Research Center, Grenoble University)
  • Pr. Pascal DEFAYE (CHU, Grenoble Hospital)
  • Pr. Michel GALINIER (CHU Rangueil, Toulouse Hospital)
  • Pr Pascal DE GROOTE (CHU Lille Hospital)
  • Pr. Jean-Sébastien HULOT (APHP, Paris Hospitals)
  • Pr. Philippe MABO (CHU, Rennes Hospital)
  • Pr. Atul PATHAK (H Princesse Grace, Monaco Hospital)
  • Pr. Rémi SABATIER (CHU, Caen Hospital)
  • Dr. Muriel SALVAT (CHU, Grenoble Hospital)
  • Pr. Jean-Noël TROCHU (CHU Nantes Hospital)

Veterinary

  • Dr. Ridha FRIKHA (VetagroSup, TIMC Research Center, Grenoble)
  • Dr. Jean-Jacques THIBAULT (Vetagrosup, TIMC Research Center, Grenoble)

Endoscopy

  • Dr. Gabriel RAHMI (HEGP, Paris Hospital)
  • Dr. Patrick TUVIGNON (CHU, Grenoble Hospital)

Signal acquisition

  • Pr. Pierre-Yves GUMERY (CNRS, TIMC Research Center, Grenoble)
  • Pr. Alfredo HERNANDEZ (INSERM, LTSI Rennes)

looking for…

Medtech enthusiasts ready to join us in our journey to save heart failure patients from emergency care.

Please send us your application at jobs (at) sentinhealth.com if you are:

Ambitious

Agile

Unconventional

Rigorous

team-minded

partners

w

We are proud to work with a network of cutting-edge partners.

what’s up ?

Since 2017, our project has been granted or awarded by :

Sentinhealth joins Belicim consortium

Feb. 2020

Public partners, namely BPI, the AURA region and Grenoble Alpes Métropole, have announced their support for funding the collaborative BELICIM project bringing together SentinHealth, Grenoble Alpes university, CHU Grenoble Alpes under the leadership of IC’Alps.
The major objective of BELICIM is the development of a platform based on specific integrated circuits (sensor interface, calculation, RF communication, power supply) increasing the performance of medical implants, reducing costs and development times and meeting the requirements of medical certifications.

Real World 4 Clinic (RW4C) funded in EIT Health 2020 BP

July 2019

RealWorld4Clinic is a new European initiative bringing real-world data to pivotal clinical research and outpatient cardiology care.
RealWorld4Clinic is a collaborative project funded by EIT Health for 3-years and lead by Profil, a German Contract Research Organization.

Sentinhealth joins EIT Health

May 2019

EIT Health connects best-in-class innovators to markets, funding and expertise across Europe. It is a body of the European Union.

ANR DIGS granted

July 2018

Lead by François Boucher and Pierre-Yves Guméry from UGA, the DIGS project has been granted by ANR during the 2018 call. This project is focused on biomarkers extraction using signal processing. Partners are TIMC and LRB from Grenoble Alpes Université, LTSI from Rennes University and Sentinhealth.

FEDER project granted

June 2018

Auvergne Rhône-Alpes region has validated our Innovation proposal jointly with IC’Alps, TIMC, LRB and INRA.

IDEX Innovation grant

May 2018

Grenoble Idex supports us via a 4 years labcom.

CIFRE financed by ANRT

January 2018

PhD on Gastric Medical Device

contact us

9 + 14 =